home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

p53 Ways To Kill A Cell

  April, 7 2003 8:17
your information resource in human molecular genetics
Some damaged cells can be fixed, but others have to die. It has been a puzzle how the tumour suppressor p53 determines the cell's fate depending on the damage done. This week’s Nature (Vol. 422, No. 6931, pp. 527-531, 03 April 2003) reports that the phosphatase PAC1 is necessary and sufficient to induce p53-dependent cell death.

The tumour suppressor p53 coordinates various cellular processes by regulating the transcription of specific genes. Yuxin Yin of the College of Physicians and Surgeons, Columbia University, New York now show that the transcription of PAC1 — known to inactivate the MAP kinase cell-survival pathway — is directly regulated by p53.

PAC1 is activated only by stress that results in the cell's demise — for example, oxidative damage — and not in response to gamma-irradiation, which causes cell-cycle arrest. "This explains how p53 may suppress the MAP kinase pathway to kill cancer cells," the authors conclude.

Unexpectedly, p53 activates the transcription of PAC1 in a rather unusual manner: it binds a ‘palindromic’ site in the PAC1 promoter, rather than the ‘consensus’ p53-binding site.


Yuxin Yin
tel +1 212 305 5699
e-mail yy151@columbia.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.